Biostem Technologies Inc
OTC:BSEM

Watchlist Manager
Biostem Technologies Inc Logo
Biostem Technologies Inc
OTC:BSEM
Watchlist
Price: 13.922 USD 3.2% Market Closed
Market Cap: 227.5m USD
Have any thoughts about
Biostem Technologies Inc?
Write Note

Wall Street
Price Targets

BSEM Price Targets Summary
Biostem Technologies Inc

Wall Street analysts forecast BSEM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BSEM is 33.15 USD with a low forecast of 32.825 USD and a high forecast of 34.125 USD.

Lowest
Price Target
32.825 USD
136% Upside
Average
Price Target
33.15 USD
138% Upside
Highest
Price Target
34.125 USD
145% Upside
Biostem Technologies Inc Competitors:
Price Targets
PER
Percheron Therapeutics Ltd
194% Upside
053030
Binex Co Ltd
122% Upside
PBH
Prestige Consumer Healthcare Inc
6% Upside
EOLS
Evolus Inc
90% Upside
13
HUTCHMED (China) Ltd
49% Upside
ZVRA
Zevra Therapeutics Inc
123% Upside

Revenue
Forecast

Revenue Estimate
Biostem Technologies Inc

For the last 12 years the compound annual growth rate for Biostem Technologies Inc's revenue is 23%. The projected CAGR for the next 2 years is 348%.

23%
Past Growth
348%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Biostem Technologies Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Biostem Technologies Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BSEM's stock price target?
Price Target
33.15 USD

According to Wall Street analysts, the average 1-year price target for BSEM is 33.15 USD with a low forecast of 32.825 USD and a high forecast of 34.125 USD.

What is Biostem Technologies Inc's Revenue forecast?
Projected CAGR
348%

For the last 12 years the compound annual growth rate for Biostem Technologies Inc's revenue is 23%. The projected CAGR for the next 2 years is 348%.

Back to Top